Ring Mountain Capital’s AbbVie ABBV Stock Holding History

Ring Mountain Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472K	Sell	1,878 -7	-0.4%	-$1.51K	0.2%	62
2026 Q1	$410K	Buy	1,885 +10	+0.5%	+$2.22K	0.22%	60
2025 Q4	$402K	Buy	1,875 +15	+0.8%	+$3.42K	0.21%	61
2025 Q3	$431K	Sell	1,860 -21	-1%	-$4.28K	0.24%	56
2025 Q2	$356K	Buy	1,881 +10	+0.5%	+$1.86K	0.22%	62
2025 Q1	$392K	Buy	1,871 +67	+4%	+$13K	0.29%	54
2024 Q4	$321K	Buy	+1,804	New	+$332K	0.21%	66

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ring Mountain Capital's ABBV Position: Q2 2026 in Review

Ring Mountain Capital reduced its AbbVie (ABBV) stake by 0.37% in Q2 2026, selling an estimated $1.51K and leaving 1,878 shares worth $472K. The position accounts for 0.2% of the portfolio, ranked #62.

Ring Mountain Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ring Mountain Capital held 1,878 shares of AbbVie worth $472K as of Q2 2026.
Ring Mountain Capital sold 7 AbbVie shares in Q2 2026, an estimated $1.51K.
AbbVie made up 0.2% of Ring Mountain Capital's portfolio in Q2 2026, its #62 holding.
Ring Mountain Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ring Mountain Capital's 13F filing for Q2 2026, filed 11 Aug 2026.